Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00601744 · ClinicalTrials.gov registry record
Social-Psychological Aspects of Orbital Exenteration
A clinical trial, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- 33
- Enrollment target
NCT00601744: Completed study, sponsored by M.D. Anderson Cancer Center.
NCT00601744 is a clinical trial that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 33 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00601744 has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- 33 participants
- Enrollment target
Study Summary
The goal of this research study is to learn about the social and emotional factors that may affect the quality of life of patients with cancer of the eye or eye area who have had their facial appearance changed due to an orbital exenteration.
Interventions
- BEHAVIORAL Questionnaire
- BEHAVIORAL Audio-Taped Interview
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 33 participants |
| Start Date | 2008-01 |
| Est. Completion | 2013-01 |
What the finished NCT00601744 record still lists
NCT00601744 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 33 participants, a relatively small participant target.
The record links to 0 conditions, and to 2 interventions - of which Questionnaire is the first listed.
NCT00601744 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00601744 about?
NCT00601744 is a clinical study titled "Social-Psychological Aspects of Orbital Exenteration". The goal of this research study is to learn about the social and emotional factors that may affect the quality of life of patients with cancer of the eye or eye area who have had their facial appearance changed due to an orbital exenteration.
What is the current status of trial NCT00601744?
This trial is currently completed. The enrollment target is 33 participants. The study started on 2008-01. Estimated completion is 2013-01.
What interventions are being tested in trial NCT00601744?
The interventions under investigation include: Questionnaire (BEHAVIORAL), Audio-Taped Interview (BEHAVIORAL).
Who is sponsoring clinical trial NCT00601744?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02861898 · 33 participants · Phase 1
Super-selective Intra-arterial Repeated Infusion of Cetuximab for the Treatment of Newly Diagnosed Glioblastoma
- NCT04871607 · 33 participants · Phase 2
Yttrium-90 Labeled Anti-CD25 Monoclonal Antibody Combined With BEAM Chemotherapy Conditioning for the Treatment of Primary Refractory or Relapsed Hodgkin Lymphoma
- NCT05071937 · 33 participants · Phase 2
ZEN003694 Combined With Talazoparib in Patients With Recurrent Ovarian Cancer
- NCT05168618 · 33 participants · Phase 2
Cabozantinib and Atezolizumab for the Treatment of Metastatic Castration-Resistant Prostate Cancer, The AtezoCab Trial
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia